SCHEMBL2074745

SCHEMBL2074745

CC12COC(OC1)OC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24342353 0.67
SCHEMBL16492586 0.67
SCHEMBL10207635 0.65
SCHEMBL13464474 0.63
SCHEMBL10993282 0.61
SCHEMBL24953025 0.60
SCHEMBL30114 0.59
SCHEMBL373951 0.57
SCHEMBL11411985 0.57
SCHEMBL1077246 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405343-A1 PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2024-07-31 EP disclosed
CN-116194082-A Retinal bioavailability of synthetic ultralong chain polyunsaturated fatty acids 犹他大学研究基金会 2023-05-30 CN disclosed
WO-2023046698-A1 PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2023-03-30 WO disclosed
US-20210347941-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS (US) 2021-11-11 US disclosed
US-10941248-B2 Methods for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2021-03-09 US disclosed
US-20200246471-A1 POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS NEKTAR THERAPEUTICS (US) 2020-08-06 US disclosed
US-10246481-B2 Bile acid derivatives and methods for synthesis and use CITY OF HOPE (US) 2019-04-02 US disclosed
US-20190055354-A1 METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2019-02-21 US disclosed
US-10144804-B2 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2018-12-04 US disclosed
US-20180319836-A1 BILE ACID DERIVATIVES AND METHODS FOR SYNTHESIS AND USE HOPE CITY (US) 2018-11-08 US disclosed
EP-1891005-A2 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2 ALPHA DERIVATIVES INSTYTUT FARMACEUTYCZNY (PL) 2008-02-27 EP disclosed
US-7285566-B2 Resistance-repellent retroviral protease inhibitors SEQUOIA PHARMACEUTICALS, INC. 2007-10-23 US disclosed
US-20070015782-A1 Benzimidazole compound EISAI CO., LTD. 2007-01-18 US disclosed
WO-2006112742-A2 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES INSTYTUT FARMACEUTYCZNY (PL) 2006-10-26 WO disclosed
EP-1656410-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS Nektar Therapeutics Al, Corporation (US) 2006-05-17 EP disclosed
US-20050054816-A1 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS 2005-03-10 US disclosed
WO-2005010075-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS AL, CORPORATION (US) 2005-02-03 WO disclosed
WO-1994012058-A1 BRIDGED CARBOXYLIC ORTHO ESTER SWEETENER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-06-09 WO disclosed
US-5298272-A Bridged carboxylic ortho ester sweetener THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-03-29 US disclosed
US-4668722-A Hindered piperidinoalcohol 1,1,1-trioxyalkane stabilizers MACK GERRY P 1987-05-26 US disclosed